RPEX Trademark

Trademark Overview

On Monday, November 30, 2020, a trademark application was filed for RPEX with the United States Patent and Trademark Office. The USPTO has given the RPEX trademark a serial number of 90348212. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, March 27, 2023. This trademark is owned by ImmunoPrecise Antibodies Ltd.. The RPEX trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Biomanufacturing for others, namely, generation and purification of antibodies for research use, scientific diagnostic use, diagnostic research use, diagnostic medical research use, industrial scientific use, industrial research use, use in industrial manufacturing processes, laboratory research use, and scientific use; Biomanufacturing for others, namely, generation and purification of antibodies for therapeutic medical use, diagnostic veterinary use and therapeutic veterinary use
rpex

General Information

Serial Number90348212
Word MarkRPEX
Filing DateMonday, November 30, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, March 27, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 15, 2021

Trademark Statements

Goods and ServicesBiomanufacturing for others, namely, generation and purification of antibodies for research use, scientific diagnostic use, diagnostic research use, diagnostic medical research use, industrial scientific use, industrial research use, use in industrial manufacturing processes, laboratory research use, and scientific use; Biomanufacturing for others, namely, generation and purification of antibodies for therapeutic medical use, diagnostic veterinary use and therapeutic veterinary use
Pseudo MarkR PEX

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, February 4, 2021
Primary Code040
First Use Anywhere DateSunday, September 30, 2007
First Use In Commerce DateSunday, September 30, 2007

Trademark Owner History

Party NameImmunoPrecise Antibodies Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressVictoria, B.C. V8Z7X8
CA
Party NameImmunoPrecise Antibodies Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVictoria, B.C. V8Z7X8
CA

Trademark Events

Event DateEvent Description
Thursday, December 3, 2020NEW APPLICATION ENTERED
Thursday, February 4, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 10, 2021ASSIGNED TO EXAMINER
Monday, May 10, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 15, 2021PUBLISHED FOR OPPOSITION
Tuesday, June 15, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 10, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 10, 2022SOU EXTENSION 1 FILED
Monday, March 14, 2022ABANDONMENT - NO USE STATEMENT FILED
Monday, March 14, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, March 15, 2022NOTICE OF REVIVAL - E-MAILED
Tuesday, March 15, 2022USE AMENDMENT FILED
Tuesday, March 15, 2022TEAS PETITION TO REVIVE RECEIVED
Tuesday, March 15, 2022SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, March 15, 2022PETITION TO REVIVE-GRANTED
Tuesday, March 15, 2022TEAS STATEMENT OF USE RECEIVED
Friday, April 8, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 9, 2022SOU EXTENSION 1 GRANTED
Friday, September 9, 2022STATEMENT OF USE PROCESSING COMPLETE
Saturday, September 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 12, 2022SU - NON-FINAL ACTION - WRITTEN
Monday, September 12, 2022NON-FINAL ACTION E-MAILED
Monday, September 12, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 27, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, March 27, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, March 27, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Related Keywords

rpex research diagnostic industrial scientific others therapeutic veterinary purification medical namely